The Medical Research Commercialisation Fund (MRCF) was established in  2007 and is a collaboration among Australia’s major  superannuation funds, Australia’s leading medical research institutes and research hospitals. MRCF has secured a total of $380 million over three separate funding rounds in investment capital.

All rounds, running from 2007 through to 2022,have been supported on behalf of the WA State Government by the Department of Jobs, Tourism, Science and Innovation (JTSI) together with the Department of Health.

The WA State government’s financial support has led to access to substantial investment in two of the State’s medical companies with a commitment of $26 million, subject to milestones, in the past two years.

This has led to 22 jobs being created in the newly established companies of OncoRes and Respirion

_{Pictured-Christine, Isobel, Ruby and Gerald Donaldson – The family of two girls with cystic fibrosis are hopeful after Telethon Kids Institute spin-off company, Respirion, receives $20 million in funding to develop a promising new therapy}